BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 12796386)

  • 1. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer.
    Jeanmart M; Lantuejoul S; Fievet F; Moro D; Sturm N; Brambilla C; Brambilla E
    Clin Cancer Res; 2003 Jun; 9(6):2195-203. PubMed ID: 12796386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
    Brambilla E; Gazzeri S; Moro D; Lantuejoul S; Veyrenc S; Brambilla C
    Clin Cancer Res; 1999 Feb; 5(2):243-50. PubMed ID: 10037171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.
    Brambilla E; Gazzeri S; Lantuejoul S; Coll JL; Moro D; Negoescu A; Brambilla C
    Clin Cancer Res; 1998 Jul; 4(7):1609-18. PubMed ID: 9676834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium.
    Lam S; leRiche JC; McWilliams A; Macaulay C; Dyachkova Y; Szabo E; Mayo J; Schellenberg R; Coldman A; Hawk E; Gazdar A
    Clin Cancer Res; 2004 Oct; 10(19):6502-11. PubMed ID: 15475437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus.
    Thiberville L; Payne P; Vielkinds J; LeRiche J; Horsman D; Nouvet G; Palcic B; Lam S
    Cancer Res; 1995 Nov; 55(22):5133-9. PubMed ID: 7585560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
    Rusch V; Klimstra D; Linkov I; Dmitrovsky E
    Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher levels of the anti-inflammatory protein CC10 are associated with improvement in bronchial dysplasia and sputum cytometric assessment in individuals at high risk for lung cancer.
    Chen J; Lam S; Pilon A; McWilliams A; Macaulay C; Szabo E
    Clin Cancer Res; 2008 Mar; 14(5):1590-7. PubMed ID: 18316584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural course of preneoplastic lesions in bronchial epithelium.
    Breuer RH; Pasic A; Smit EF; van Vliet E; Vonk Noordegraaf A; Risse EJ; Postmus PE; Sutedja TG
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):537-43. PubMed ID: 15701838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
    Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
    J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
    Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
    Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
    Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
    Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
    Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
    Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.
    Keith RL; Miller YE; Gemmill RM; Drabkin HA; Dempsey EC; Kennedy TC; Prindiville S; Franklin WA
    Clin Cancer Res; 2000 May; 6(5):1616-25. PubMed ID: 10815878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and carcinoma of the stomach.
    Sun Y; Li JY; He JS; Zhou LX; Chen K
    Histopathology; 2005 May; 46(5):505-14. PubMed ID: 15842632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 in preneoplastic and early neoplastic bronchial lesions.
    Martin B; Verdebout JM; Mascaux C; Paesmans M; Rouas G; Verhest A; Ninane V; Sculier JP
    Oncol Rep; 2002; 9(2):223-9. PubMed ID: 11836584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
    Kalomenidis I; Orphanidou D; Papamichalis G; Vassilakopoulos T; Scorilas A; Rasidakis A; Papastamatiou H; Jordanoglou J; Roussos C
    Lung; 2001; 179(5):265-78. PubMed ID: 11976895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer.
    Crowell RE; Gilliland FD; Temes RT; Harms HJ; Neft RE; Heaphy E; Auckley DH; Crooks LA; Jordan SW; Samet JM; Lechner JF; Belinsky SA
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):631-7. PubMed ID: 8824366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.
    Papadimitrakopoulou VA; Izzo J; Mao L; Keck J; Hamilton D; Shin DM; El-Naggar A; den Hollander P; Liu D; Hittelman WN; Hong WK
    Clin Cancer Res; 2001 Oct; 7(10):3127-34. PubMed ID: 11595705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.